JG

Jyoti Gupta

Active Director Director DIN 09243560
DIN 09243560 First appointment Jul 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Jyoti Gupta

Data last updated:

Jyoti Gupta is a Director at Pinakin Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Pinakin Pharmaceuticals Private Limited reported revenue of ₹19 Lakh (FY 2024).

DIN 09243560
Primary Designation Director
Industry Trading
First Appointment 19 Jul 2021
Oldest Company Age 12 yrs
Largest company Pinakin Pharmaceuticals Private Limited · ₹19 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jul 20212014₹19 Lakh (FY 2024)Active

Board colleagues of Jyoti Gupta

Directorship timeline

Open interactive timeline →
Pinakin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyoti Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Gupta

Jyoti Gupta currently holds 1 directorship: Pinakin Pharmaceuticals Private Limited (Director, since 19 Jul 2021, revenue ₹19 Lakh (FY 2024)).

Jyoti Gupta was first appointed on 19 Jul 2021 as Director at Pinakin Pharmaceuticals Private Limited.

The current boards of Jyoti Gupta's companies include Ankit Gupta (Pinakin Pharmaceuticals Private Limited), Shashi Gupta (Pinakin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available